SCHEMBL1694775

SCHEMBL1694775

Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cccnc5)cnc(N)c34)cc2)c1.Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccncc5)cnc(N)c34)cc2)c1

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 16/20 0.97
CYP3A4 P08684 2/20 0.97
AURKB Q96GD4 10/20 0.83
BRAF P15056 4/20 0.76
PLK4 O00444 4/20 0.73
AURKA O14965 4/20 0.73
ROCK2 O75116 4/20 0.73
ABL1 P00519 4/20 0.73
NTRK1 P04629 4/20 0.73
LCK P06239 4/20 0.73
CSF1R P07333 4/20 0.73
LYN P07948 4/20 0.73
KIT P10721 4/20 0.73
FGFR1 P11362 4/20 0.73
FLT1 P17948 4/20 0.73
FLT3 P36888 4/20 0.73
BLK P51451 4/20 0.73
NEK2 P51955 4/20 0.73
LIMK1 P53667 4/20 0.73
STK3 Q13188 4/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL233442 0.98 KDR (1.00) KDRCYP3A4AURKBBRAFPLK4
SCHEMBL231766 0.96 KDR (1.00) KDRCYP3A4AURKBPLK4AURKA
SCHEMBL3530163 0.91 KDR (1.00) KDRCYP3A4AURKBPLK4AURKA
SCHEMBL3529454 0.91 KDR (1.00) KDRCYP3A4AURKBBRAFPLK4
SCHEMBL3530382 0.91 KDR (0.93) KDRCYP3A4AURKBPLK4AURKA
SCHEMBL3530051 0.90 KDR (0.91) KDRCYP3A4AURKBPLK4AURKA
SCHEMBL3558774 0.89 KDR (0.89) KDRCYP3A4AURKBPLK4AURKA
SCHEMBL3571962 0.89 KDR (0.88) KDRCYP3A4AURKBPLK4AURKA
SCHEMBL1694778 0.88 KDR (0.76) KDRCYP3A4AURKBBRAFPLK4
SCHEMBL3531408 0.88 KDR (1.00) KDRCYP3A4AURKBPLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588098-A1 COMPOUNDS FOR THE TREATMENT OF POSTERIOR SEGMENT DISORDERS AND DISEASES Alcon Research, Ltd. (US) 2013-05-08 EP claimed
WO-2012003141-A1 COMPOUNDS FOR THE TREATMENT OF POSTERIOR SEGMENT DISORDERS AND DISEASES ALCON RESEARCH, LTD. (US) 2012-01-05 WO claimed